Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Boulle

Showing results (131-140 of 240) with videos related to

Pageof 24
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2018
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort StudyYing Zhao, Tamaryn Fox, Kathryn Manning, et al.
Plos Medicine|May 24, 2021
The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goalsPeter Ehrenkranz, Sydney Rosen, Andrew Boulle, et al.
Journal of the International AIDS Society|July 11, 2017
HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studiesLukas Fenner, Andrew Atkinson, Andrew Boulle, et al.
AIDS (London, England)|November 18, 2011
The causal effect of switching to second-line ART in programmes without access to routine viral load monitoringThomas Gsponer, Maya Petersen, Matthias Egger, et al.
Tropical Medicine & International Health : TM & IH|August 13, 2011
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa CollaborationMary-Ann Davies, Andrew Boulle, Brian Eley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2015
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyNicky Longley, Joseph Nicholas Jarvis, Graeme Meintjes, et al.
Plos One|February 14, 2017
First-line antiretroviral drug discontinuations in childrenMelony Fortuin-de Smidt, Reneé de Waal, Karen Cohen, et al.
JMIR Public Health and Surveillance|April 5, 2018
Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan AfricaBrian Rice, Andrew Boulle, Stefan Baral, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 5, 2010
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaborationMary-Ann Davies, Olivia Keiser, Karl Technau, et al.
BMC Pregnancy and Childbirth|May 5, 2021
Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South AfricaDorothy C Nyemba, Emma Kalk, Hlengiwe P Madlala, et al.
Pageof 24

Showing results (131-140 of 240) with videos related to

Sort By:
Pageof 24
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2018
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort StudyYing Zhao, Tamaryn Fox, Kathryn Manning, et al.
Plos Medicine|May 24, 2021
The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goalsPeter Ehrenkranz, Sydney Rosen, Andrew Boulle, et al.
Journal of the International AIDS Society|July 11, 2017
HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studiesLukas Fenner, Andrew Atkinson, Andrew Boulle, et al.
AIDS (London, England)|November 18, 2011
The causal effect of switching to second-line ART in programmes without access to routine viral load monitoringThomas Gsponer, Maya Petersen, Matthias Egger, et al.
Tropical Medicine & International Health : TM & IH|August 13, 2011
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa CollaborationMary-Ann Davies, Andrew Boulle, Brian Eley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2015
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyNicky Longley, Joseph Nicholas Jarvis, Graeme Meintjes, et al.
Plos One|February 14, 2017
First-line antiretroviral drug discontinuations in childrenMelony Fortuin-de Smidt, Reneé de Waal, Karen Cohen, et al.
JMIR Public Health and Surveillance|April 5, 2018
Strengthening Routine Data Systems to Track the HIV Epidemic and Guide the Response in Sub-Saharan AfricaBrian Rice, Andrew Boulle, Stefan Baral, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 5, 2010
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaborationMary-Ann Davies, Olivia Keiser, Karl Technau, et al.
BMC Pregnancy and Childbirth|May 5, 2021
Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South AfricaDorothy C Nyemba, Emma Kalk, Hlengiwe P Madlala, et al.
Pageof 24